Metropolitan Life Insurance Company (MetLife)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-694	Closed	-$87K	–	2510
2017 Q4	$87K	Sell	694 -704	-50%	-$90.2K	﹤0.01%	2387
2017 Q3	$191K	Hold	1,398	–	–	﹤0.01%	2302
2017 Q2	$199K	Buy	+1,398	New	+$216K	﹤0.01%	2339
2016 Q1	–	Sell	-1,265	Closed	-$254K	–	2545
2015 Q4	$254K	Hold	1,265	–	–	﹤0.01%	2074
2015 Q3	$189K	Hold	1,265	–	–	﹤0.01%	2323
2015 Q2	$1.2M	Buy	1,265 +75	+6%	+$61.3K	0.01%	1172
2015 Q1	$872K	Buy	1,190 +149	+14%	+$112K	0.01%	1276
2014 Q4	$827K	Buy	1,041 +147	+16%	+$79.1K	0.01%	1458
2014 Q3	$357K	Hold	894	–	–	﹤0.01%	1954
2014 Q2	$241K	Buy	+894	New	+$192K	﹤0.01%	2375

Other funds holding TTPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TTPH Position: Q1 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2018, closing a stake of 694 shares — an estimated $87K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TTPH in Q2 2014 and held it in 10 quarters. The position peaked at $1.2M in Q2 2015. 94 funds tracked by Wall St. Rank hold TTPH as of Q1 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 694 Tetraphase Pharmaceuticals, Inc. shares in Q1 2018, an estimated $87K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s Tetraphase Pharmaceuticals, Inc. position peaked at $1.2M in Q2 2015.
94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.